
Scott L Friedman MD
Hepatology & Liver Transplantation
Professor, Medicine, Icahn School of Medicine
Join to View Full Profile
1 Gustave L Levy PlNew York, NY 10029
Phone+1 212-241-7270
Fax+1 212-241-4465
Dr. Friedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Gastroenterology, 1982 - 1985
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1980 - 1982
Icahn School of Medicine at Mount SinaiClass of 1979
Certifications & Licensure
CA State Medical License 1982 - Present
NY State Medical License 1997 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow (AGAF) American Gastroenterological Association, 2007
- Elected Member The American Society for Clinical Investigation, 1995
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Bridging dimensions: a comparative analysis of 2D and 3D in vitro models for hepatocellular carcinoma research.Leticia C Valente, Luana Riechelman-Casarin, Laura L P Esteves, Gabriel P Bacil, Tereza Cristina da Silva
Archives of Toxicology. 2025-11-01 - 2 citationsChimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases.Elmar Jaeckel, Scott L Friedman, Michael Hudecek, Ulrike Protzer
Journal of Hepatology. 2025-11-01 - 1 citationsACLY inhibition promotes tumour immunity and suppresses liver cancer.Jaya Gautam, Jianhan Wu, James S V Lally, Jamie D McNicol, Russta Fayyazi
Nature. 2025-09-01
Journal Articles
- Autophagy Is a Gatekeeper of Hepatic Differentiation and Carcinogenesis by Controlling the Degradation of YapKirk N Campbell, Mark J Czaja, M Isabel Fiel, Kemal M Akat, Scott L Friedman, Nature
- Mechanisms of NAFLD Development and Therapeutic StrategiesArun J Sanyal, Mary Rinella, Scott L Friedman, Nature
Other
- Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and diagnosisFriedman SL, Larson AM, Burns MJ
http://www.uptodate.com/contents/acetaminophen-paracetamol-poisoning-in-adults-pathophysiology-prese
UpToDate, Wolters Kluwer Health - 2013-01-12 - Alcoholic hepatitis: Clinical manifestations and diagnosisFriedman SL
http://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis
UpToDate, Wolters Kluwer Health - 2013-02-19 - Alcoholic hepatitis: Natural history and managementFriedman SL
http://www.uptodate.com/contents/alcoholic-hepatitis-natural-history-and-management
UpToDate, Wolters Kluwer Health - 2013-01-29 - Join now to see all
Press Mentions
A New Hub for Liver Research Tackles Its First InvestigationsOctober 7th, 2025
Mount Sinai Institute for Liver Research Established to Advance Understanding and Treatment of Liver Disease Amid Global ConcernsMay 7th, 2025
Statins Appear to Guard Against Liver Disease ProgressionMay 15th, 2023- Join now to see all
Grant Support
- Training Program in Investigative Gastroenterology and HepatologyICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2028
- Hepatic stellate cells in NASH fibrosis and HCCICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2021–2025
- Therapeutic antibodies for treating liver fibrosisABALONE BIO, INC.2020–2025
- Role Of Stellate Cells In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases2011–2012
- Autophagy During Hepatic Stellate Cell Activation In Alcoholic Liver InjuryNational Institute On Alcohol Abuse And Alcoholism2011
- Project 2National Institute On Alcohol Abuse And Alcoholism2010–2011
- Project 1National Institute On Alcohol Abuse And Alcoholism2010–2011
- Pilot Feasibility Project #3National Institute On Alcohol Abuse And Alcoholism2010–2011
- Pilot Feasibility Project #2National Institute On Alcohol Abuse And Alcoholism2010–2011
- Pilot Feasibility Project #1National Institute On Alcohol Abuse And Alcoholism2010–2011
- Oxidant Stress And Fibrosis In Alcoholic Liver InjuryNational Institute On Alcohol Abuse And Alcoholism2010–2011
- Models CoreNational Institute On Alcohol Abuse And Alcoholism2010–2011
- Mentoring Junior Faculty In Alcoholic Liver DiseaseNational Institute On Alcohol Abuse And Alcoholism2010–2011
- Administrative CoreNational Institute On Alcohol Abuse And Alcoholism2010–2011
- Training Program In Investigative GastroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- The Role Of KLF6 Tumor Suppressor In Hepatocellular CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Mentoring Junior Faculty In Alcoholic Liver DiseaseNational Institute On Alcohol Abuse And Alcoholism2009
- International Symposium On Alcoholic Liver And Pancreatic Disease (ALPD)National Institute On Alcohol Abuse And Alcoholism2009
- The Role Of KLF6 Tumor Suppressor In Hepatocellular CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2009
- Project 2National Institute On Alcohol Abuse And Alcoholism2008–2009
- Project 1National Institute On Alcohol Abuse And Alcoholism2008–2009
- Pilot Feasibility Project #3National Institute On Alcohol Abuse And Alcoholism2008–2009
- Pilot Feasibility Project #2National Institute On Alcohol Abuse And Alcoholism2008–2009
- Pilot Feasibility Project #1National Institute On Alcohol Abuse And Alcoholism2008–2009
- Oxidant Stress And Fibrosis In Alcoholic Liver InjuryNational Institute On Alcohol Abuse And Alcoholism2008–2009
- Models CoreNational Institute On Alcohol Abuse And Alcoholism2008–2009
- Administrative CoreNational Institute On Alcohol Abuse And Alcoholism2008–2009
- The Role Of KLF6 In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- Training Program In Investigative GastroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2009
- Role Of KLF6 Tumor Suppressor In Hepatocellular CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2007
- DDR2 Receptor Tyrosine Kinase In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
- The Role Of Stellate Cells In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
- Lipocytes And Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1997–1998
- Lipocytes And Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1997
- The Role Of Lipocytes In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1993
- R0le Of Lipocytes In Hepatic Fibrosis 0National Institute Of Diabetes And Digestive And Kidney Diseases1992
- Role Of Lipocytes In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1990
- The Role Of Lipocytes In Hepatic Collagen MetabolismNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









